Your SlideShare is downloading. ×
Pharmaceutical products of the future 50 company biopharma and traditional pipeline analysis to 2016
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pharmaceutical products of the future 50 company biopharma and traditional pipeline analysis to 2016

203
views

Published on

The report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the …

The report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade.

Published in: Business, News & Politics

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
203
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pharmaceutical Products of the Future: 50-Company Biopharma and TraditionalPipeline Analysis to 2016There are an estimated 724 projects in development from the top 50 pharmaceutical companies. Together, they have the potential to add billions in value to the current pharmaceutical market in the nextfive years. What types of drugs are companies developing and what will be the impact of these productson the marketplace and key competitors? In this report, Kalorama Information has analyzed the late-stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies that produce the lionsshare of industry revenues.Get your copy of this report @ http://www.reportsnreports.com/reports/190914-pharmaceutical-products-of-the-future-50-company-biopharma-and-traditional-pipeline-analysis-to-2016.htmlReport Details:Published: August 2012No. of Pages: 220Price: Single User License – US$2500 Corporate User License – US$5000Coverage of the 50 Leading Companies This report takes a look at the pipeline of the following companies. The top companies includepharmaceutical companies that are considered to be the top 50 companies worldwide in terms ofgenerated revenues, these include:  Abbott Laboratories  Actelion  Allergan  Amgen  Astellas  AstraZeneca  Baxter International  Bayer  Biogen IDEC  Boehringer Ingelheim  Bristol-Myers Squibb
  • 2.  Celgene Corp.  CSL  Daiichi Sankyo  Dainippon Sumitomo  Eisai  Eli Lilly & Co.  Forest  Gilead Sciences  GlaxoSmithKline  Grifols SA  Hospira  Johnson & Johnson  Kyowa Kirin  Lundbeck  Menarini  Merck  Merck KGaA  Mitsubishi Tanabe Pharma  Mylan  Novartis  Novo Nordisk  Ono Pharmaceutical Co.  Otsuka Pharmaceutical  Pfizer  Purdue Pharma  Reckitt Benckiser  Roche  Sanofi  Santen Pharmaceuticals  Servier  Shionogi  Shire  Taisho Pharmacueitcal  Takeda  TEVA  UCB  Valeant Pharmaceuticals  Warner Chilcott  WatsonWhile the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role ofbiopharmaceutical products. The growing interest in biotechnology development has transitioned thepharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merckand Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a
  • 3. pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/orthrough their own in-house research efforts.Pipeline Analysis, Key Trends, Market Forecasts This Kalorama Information market research report captures these trends, extracting sales for allpharmaceutical and biopharmaceutical products (excluding prophylactic vaccines and OTC products) andproviding estimates and forecasts of the world biopharma market.As part of its coverage, the report provides the following:  Company Analysis  Pipeline Snapshot: Top 20 Companies  Market Trends and Value  Evaluating Changes in 2011 Market Value  The Traditional Pharmaceutical Market  Biotechnology Market Facts and ForecastFor the purpose of this study, Kalorama Information has extracted sales for human pharmaceutical andbiopharmaceutical products; consumer pharmaceuticals and products; diagnostics; devices; chemicals;agriculture; and animal health. These are areas where many of these companies also compete withsignificant market shares.The industry has struggled in recent years but many observers see biopharmaceutical as the key tocontinued success for market leaders. Biopharmaceuticals are defined as any substance produced bynatural organisms or recombinant techniques consisting of proteins and other products derived from livingorganisms for the treatment or management of diseases or injuries. Biopharmaceuticals are createdthrough fermentation, recombinant DNA technology, and other bioprocesses. The complex nature ofbiopharmaceuticals and the growing interest in development of these products has resulted in a flood ofnew issues affecting the already complicated healthcare market. There are a number of issues and trendswhich are experienced by the healthcare industry as a whole and others which are unique tobiopharmaceuticals, their development and commercialization.Issues and Trends discussed in this report include:  Biotechnology Drug Development  Orphan Drugs  Fast Track Drug Status  Other Accelerated Methods for Drug Approval  Pharmaceutical Regulatory Exclusivity  Biosimilar Development  Aging Populations  Mergers, Acquisitions, and Collaborations
  • 4.  Contributors to R&D Success  R&D Spending Trends  The Role of Contract Research Organizations  Sustainability in a Changing Pharmaceutical IndustryExplore more reports on Pharmaceuticals @ http://www.reportsnreports.com/market-research/pharmaceuticals/Contact:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.+ 1 888 391 5441sales@reportsandreports.comConnect With Us:

×